352 related articles for article (PubMed ID: 25613066)
1. Long noncoding RNA MALAT1 associates with the malignant status and poor prognosis in glioma.
Ma KX; Wang HJ; Li XR; Li T; Su G; Yang P; Wu JW
Tumour Biol; 2015 May; 36(5):3355-9. PubMed ID: 25613066
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of long non-coding RNA MALAT1 is correlated with clinical progression and unfavorable prognosis in pancreatic cancer.
Pang EJ; Yang R; Fu XB; Liu YF
Tumour Biol; 2015 Apr; 36(4):2403-7. PubMed ID: 25481511
[TBL] [Abstract][Full Text] [Related]
3. Up-Regulation of Long Non-Coding RNA AB073614 Predicts a Poor Prognosis in Patients with Glioma.
Hu L; Lv QL; Chen SH; Sun B; Qu Q; Cheng L; Guo Y; Zhou HH; Fan L
Int J Environ Res Public Health; 2016 Apr; 13(4):433. PubMed ID: 27104549
[TBL] [Abstract][Full Text] [Related]
4. A long noncoding RNA UCA1 promotes proliferation and predicts poor prognosis in glioma.
Zhao W; Sun C; Cui Z
Clin Transl Oncol; 2017 Jun; 19(6):735-741. PubMed ID: 28105536
[TBL] [Abstract][Full Text] [Related]
5. Tumor-suppressive function of long noncoding RNA MALAT1 in glioma cells by downregulation of MMP2 and inactivation of ERK/MAPK signaling.
Han Y; Wu Z; Wu T; Huang Y; Cheng Z; Li X; Sun T; Xie X; Zhou Y; Du Z
Cell Death Dis; 2016 Mar; 7(3):e2123. PubMed ID: 26938295
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of long non-coding RNA MALAT1 correlates with tumor progression and poor prognosis in clear cell renal cell carcinoma.
Zhang HM; Yang FQ; Chen SJ; Che J; Zheng JH
Tumour Biol; 2015 Apr; 36(4):2947-55. PubMed ID: 25480417
[TBL] [Abstract][Full Text] [Related]
7. Knockdown of long non-coding RNA MALAT1 increases the blood-tumor barrier permeability by up-regulating miR-140.
Ma J; Wang P; Yao Y; Liu Y; Li Z; Liu X; Li Z; Zhao X; Xi Z; Teng H; Liu J; Xue Y
Biochim Biophys Acta; 2016 Feb; 1859(2):324-38. PubMed ID: 26619802
[TBL] [Abstract][Full Text] [Related]
8. Aberrant NEAT1 expression is associated with clinical outcome in high grade glioma patients.
He C; Jiang B; Ma J; Li Q
APMIS; 2016 Mar; 124(3):169-74. PubMed ID: 26582084
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of lncRNA-MALAT1 Affects Proliferation and the Expression of Stemness Markers in Glioma Stem Cell Line SHG139S.
Han Y; Zhou L; Wu T; Huang Y; Cheng Z; Li X; Sun T; Zhou Y; Du Z
Cell Mol Neurobiol; 2016 Oct; 36(7):1097-107. PubMed ID: 26649728
[TBL] [Abstract][Full Text] [Related]
10. Silencing of Long Non-Coding RNA MALAT1 Promotes Apoptosis of Glioma Cells.
Xiang J; Guo S; Jiang S; Xu Y; Li J; Li L; Xiang J
J Korean Med Sci; 2016 May; 31(5):688-94. PubMed ID: 27134488
[TBL] [Abstract][Full Text] [Related]
11. Long noncoding RNA SPRY4-IT1 is a prognostic factor for poor overall survival and has an oncogenic role in glioma.
Zhou Y; Wang DL; Pang Q
Eur Rev Med Pharmacol Sci; 2016 Jul; 20(14):3035-9. PubMed ID: 27460732
[TBL] [Abstract][Full Text] [Related]
12. A novel cell cycle-associated lncRNA, HOXA11-AS, is transcribed from the 5-prime end of the HOXA transcript and is a biomarker of progression in glioma.
Wang Q; Zhang J; Liu Y; Zhang W; Zhou J; Duan R; Pu P; Kang C; Han L
Cancer Lett; 2016 Apr; 373(2):251-9. PubMed ID: 26828136
[TBL] [Abstract][Full Text] [Related]
13. Knockdown of Long Noncoding RNA CCAT2 Inhibits Cellular Proliferation, Invasion, and Epithelial-Mesenchymal Transition in Glioma Cells.
Zeng J; Du T; Song Y; Gao Y; Li F; Wu R; Chen Y; Li W; Zhou H; Yang Y; Pei Z
Oncol Res; 2017 Jul; 25(6):913-921. PubMed ID: 27938499
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of lncRNA-ATB correlates with clinical progression and unfavorable prognosis in pancreatic cancer.
Qu S; Yang X; Song W; Sun W; Li X; Wang J; Zhong Y; Shang R; Ruan B; Zhang Z; Zhang X; Li H
Tumour Biol; 2016 Mar; 37(3):3933-8. PubMed ID: 26482611
[TBL] [Abstract][Full Text] [Related]
15. Increased MALAT1 expression predicts poor prognosis in esophageal cancer patients.
Huang C; Yu Z; Yang H; Lin Y
Biomed Pharmacother; 2016 Oct; 83():8-13. PubMed ID: 27470544
[TBL] [Abstract][Full Text] [Related]
16. High Expression of Long Noncoding RNA MALAT1 Indicates a Poor Prognosis and Promotes Clinical Progression and Metastasis in Bladder Cancer.
Li C; Cui Y; Liu LF; Ren WB; Li QQ; Zhou X; Li YL; Li Y; Bai XY; Zu XB
Clin Genitourin Cancer; 2017 Oct; 15(5):570-576. PubMed ID: 28648755
[TBL] [Abstract][Full Text] [Related]
17. Prediction of relapse and prognosis by expression levels of long noncoding RNA PEG10 in glioma patients.
Xiao H; Ding N; Liao H; Yao Z; Cheng X; Zhang J; Zhao M
Medicine (Baltimore); 2019 Nov; 98(45):e17583. PubMed ID: 31702614
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA TUSC7 expression is independently predictive of outcome in glioma.
Ma XL; Zhu WD; Tian LX; Sun WD; Shang F; Lin QT; Zhang HQ
Eur Rev Med Pharmacol Sci; 2017 Aug; 21(16):3605-3610. PubMed ID: 28925483
[TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNA MALAT1 as a potential novel biomarker in digestive system cancers: a meta-analysis.
Song W; Zhang RJ; Zou SB
Minerva Med; 2016 Aug; 107(4):245-50. PubMed ID: 27348442
[TBL] [Abstract][Full Text] [Related]
20. lncRNAs as potential molecular biomarkers for the clinicopathology and prognosis of glioma: A systematic review and meta-analysis.
Zhou Q; Liu J; Quan J; Liu W; Tan H; Li W
Gene; 2018 Aug; 668():77-86. PubMed ID: 29777909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
